236 related articles for article (PubMed ID: 10443063)
1. Comparison of antihypertensive efficacy and tolerability of losartan and extended-release felodipine in patients with mild to moderate hypertension.
Hung MJ; Lin FC; Cherng WJ; Wang CH; Hung KC; Hsieh IC; Wen MS; Wu D
J Formos Med Assoc; 1999 Jun; 98(6):403-9. PubMed ID: 10443063
[TBL] [Abstract][Full Text] [Related]
2. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
7. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
8. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical efficacy and adverse effects between extended-release felodipine and atenolol in patients with mild and moderate essential hypertension.
Chern MS; Lin FC; Wu D
Changgeng Yi Xue Za Zhi; 1997 Jun; 20(2):86-93. PubMed ID: 9260367
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group.
Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC; Michelson EL
Clin Ther; 1998; 20(3):527-38. PubMed ID: 9663368
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
12. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
Antonicelli R; Omboni S; Giovanni DC; Ansuini R; Mori A; Gesuita R; Parati G; Paciaroni E
Drugs Aging; 2002; 19(7):541-51. PubMed ID: 12182690
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effect and tolerability of felodipine extended release (ER) tablets in comparison with felodipine plain tablets (PT) and placebo in hypertensives on a diuretic. Canadian Study Group.
Carruthers SG; Vint-Reed C
Clin Invest Med; 1993 Oct; 16(5):386-94. PubMed ID: 8261692
[TBL] [Abstract][Full Text] [Related]
15. Extended-release felodipine in patients with mild to moderate hypertension. Felodipine ER Dose-Response Study Group.
Weber MA; Goldberg AI; Faison EP; Lipschutz K; Shapiro DA; Nelson EB; Irvin JD
Clin Pharmacol Ther; 1994 Mar; 55(3):346-52. PubMed ID: 8143399
[TBL] [Abstract][Full Text] [Related]
16. A dose-finding, placebo-controlled study on extended-release felodipine once daily in treatment of hypertension.
Cambell LM; Ross JR; Goves JR; Lees CT; McCullagh A; Barnes P; Timerick SJ; Richardson PD
J Cardiovasc Pharmacol; 1989 Dec; 14(6):869-73. PubMed ID: 2481775
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
[TBL] [Abstract][Full Text] [Related]
18. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
Wilson TW; Lacourcière Y; Barnes CC
CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
[TBL] [Abstract][Full Text] [Related]
19. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
Mallion JM; Goldberg AI
Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
[TBL] [Abstract][Full Text] [Related]
20. A parallel group randomised comparative study of felodipine and nifedipine in hypertension.
Sharma SM; Sethi KK; Kaul UA; Arora R; Khalilullah M
Indian Heart J; 1991; 43(3):171-3. PubMed ID: 1800302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]